16. December 2011New Roche screening test for abacavir hypersensitivity available in Europe HLA-B*5701 screening provides physicians with a means to avoid prescribing drugs to patients at high risk of allergic reactions to a drug called abacavir for the treatment of HIV and AIDS.more 19. September 2011ATHENA Data Presented at International Papillomavirus Conference Support Use of Roche’s cobas® HPV Test in Primary Screening for Cervical CancerData demonstrates the cobas® HPV Test, with its option of individual HPV 16 and 18 genotyping, provides additional risk stratification for high risk HPV-positive women
more 23. August 2011Companion Diagnostic Test that Identifies Patients With Melanoma Tumor Mutation Available in Europecobas BRAF Mutation Test is used to identify patients with melanoma tumors that harbor a genetic mutation which can be treated with Zelboraf (vemurafenib)more 22. July 2011KRAS Diagnostic Test that assists with personalized treatment of colorectal cancer receives CE Markcobas KRAS Mutation Test identifies colorectal cancer patients not likely to respond to anti-EGFR antibody therapiesmore 07. June 2011Roche and Merck Collaborate to Develop Diagnostic Tests for Merck’s Investigational Cancer TherapiesMerck and Roche today announced that they have entered into a collaboration focused on the application and development of diagnostic assays for use with Merck's investigational cancer therapy portfolio.more 02. June 2011Roche and Clovis Oncology to co-develop EGFR companion diagnosticCollaboration focused on personalized treatment of non-small-cell lung cancer more 23. May 2011Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Markcobas® TaqScreen MPX Test, v2.0 provides real-time results for HIV, HCV and HBV.
more 19. May 2011Roche expands use of novel HIV testTest with enhanced reliability for monitoring HIV patients now CE markedmore 06. May 2011Roche submits application for clearance of Chlamydia and Gonorrhoeae testTest detects and expands menu on the recently approved cobas 4800 instrument
more 31. March 2011Roche's test for Cytomegalovirus is approved in EuropeRoche announced today that its Cytomegalovirus (CMV) test is now commercially available in Europe. CMV viral load testing helps physicians manage immunocompromised patients at risk of CMV disease. more 31. March 2011Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipientsNew test standardizes CMV testing for both solid organ and hematopoietic stem cell transplant recipients more 24. February 2011Pivotal Study Validates Roche's cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical CancerATHENA study shows the cobas HPV Test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70 percent of cervical cancermore 04. February 2011First Duplex Test for Parvovirus B19 and Hepatitis A Virus Now Available in the USRoche announced today that the cobas® TaqScreen DPX Test for use on the cobas s 201 system is now available in the US. It is the first commercial test to quantify ...more 18. January 2011Roche Molecular Systems launches redesigned WebsiteRoche Molecular Systems announced the launch of a new Website that’s designed with users’ needs in mind. Work on the site began in the fall of 2009, with RMD conducting ...more